Autor según el artículo: Ojeda-Montes, Maria J; Casanova-Marti, Angela; Gimeno, Aleix; Tomas-Hernandez, Sarah; Cereto-Massague, Adria; Wolber, Gerhard; Beltran-Debon, Raul; Valls, Cristina; Mulero, Miquel; Pinent, Montserrat; Pujadas, Gerard; Garcia-Vallve, Santiago
Departamento: Bioquímica i Biotecnologia
Autor/es de la URV: Beltrán Debón, Raúl Alejandro / CASANOVA MARTÍ, ANGELA / Cereto Massagué, Adrián José / Garcia Vallve, Santiago / Mulero Abellán, Miguel / OJEDA MONTES, Mª JOSÉ / Pinent Armengol, Montserrat / Pujadas Anguiano, Gerard / TOMAS HERNÁNDEZ, SARA / Valls Bautista, Cristina
Palabras clave: cd26; dipeptidyl peptidase 4; diversifying molecular scaffolds; expanding chemical space; molecular fingerprints; virtual molecular libraries; Animals; Binding sites; Cd26; Computational chemistry; Databases, chemical; Dipeptidyl peptidase 4; Dipeptidyl-peptidase iv inhibitors; Diversifying molecular scaffolds; Drug design; Expanding chemical space; Humans; Kidney; Ligands; Molecular docking simulation; Molecular fingerprints; Structure-activity relationship; Swine; Virtual molecular libraries; Virtual screening
Resumen: Aim: Fragment-based drug design or bioisosteric replacement is used to find new actives with low (or no) similarity to existing ones but requires the synthesis of nonexisting compounds to prove their predicted bioactivity. Protein-ligand docking or pharmacophore screening are alternatives but they can become computationally expensive when applied to very large databases such as ZINC. Therefore, fast strategies are necessary to find new leads in such databases. Materials & methods: We designed a computational strategy to find lead molecules with very low (or no) similarity to existing actives and applied it to DPP-IV. Results: The bioactivity assays confirm that this strategy finds new leads for DPP-IV inhibitors. Conclusion: This computational strategy reduces the time of finding new lead molecules.
Áreas temáticas: Astronomia / física; Biotecnología; Chemistry, medicinal; Ciência da computação; Ciências ambientais; Ciências biológicas i; Ciências biológicas ii; Ciências biológicas iii; Drug discovery; Enfermagem; Engenharias iv; Farmacia; General medicine; Medicina ii; Molecular medicine; Odontología; Pharmacology; Química; Saúde coletiva
Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
Direcció de correo del autor: raul.beltran@urv.cat; gerard.pujadas@urv.cat; santi.garcia-vallve@urv.cat; montserrat.pinent@urv.cat; miquel.mulero@urv.cat; cristina.valls@urv.cat; adrianjose.cereto@urv.cat
ISSN: 17568919
Fecha de alta del registro: 2024-11-23
Volumen de revista: 11
Versión del articulo depositado: info:eu-repo/semantics/acceptedVersion
Enlace a la fuente original: https://www.future-science.com/doi/10.4155/fmc-2018-0597
Referencia al articulo segun fuente origial: Future Medicinal Chemistry. 11 (12): 1387-1401
Referencia de l'ítem segons les normes APA: Ojeda-Montes, Maria J; Casanova-Marti, Angela; Gimeno, Aleix; Tomas-Hernandez, Sarah; Cereto-Massague, Adria; Wolber, Gerhard; Beltran-Debon, Raul; Va (2019). Mining large databases to find new leads with low similarity to known actives: application to find new DPP-IV inhibitors. Future Medicinal Chemistry, 11(12), 1387-1401. DOI: 10.4155/fmc-2018-0597
URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
DOI del artículo: 10.4155/fmc-2018-0597
Entidad: Universitat Rovira i Virgili
Año de publicación de la revista: 2019
Tipo de publicación: Journal Publications